These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 8978408

  • 1. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH, Chi SG, Shi XB, Voeller HJ, Jacobson JW, Gelmann EP, deVere White RW.
    J Natl Cancer Inst; 1997 Jan 01; 89(1):66-71. PubMed ID: 8978408
    [Abstract] [Full Text] [Related]

  • 2. Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay.
    Shi XB, Bodner SM, deVere White RW, Gumerlock PH.
    Diagn Mol Pathol; 1996 Dec 01; 5(4):271-8. PubMed ID: 8955619
    [Abstract] [Full Text] [Related]

  • 3. Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis.
    Bosari S, Marchetti A, Buttitta F, Graziani D, Borsani G, Loda M, Bevilacqua G, Coggi G.
    Diagn Mol Pathol; 1995 Dec 01; 4(4):249-55. PubMed ID: 8634780
    [Abstract] [Full Text] [Related]

  • 4. p53 in prostate cancer: frequent expressed transition mutations.
    Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH.
    J Natl Cancer Inst; 1994 Jun 15; 86(12):926-33. PubMed ID: 7515114
    [Abstract] [Full Text] [Related]

  • 5. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ.
    J Natl Cancer Inst; 1993 Oct 20; 85(20):1657-69. PubMed ID: 7692074
    [Abstract] [Full Text] [Related]

  • 6. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.
    Meyers FJ, Gumerlock PH, Chi SG, Borchers H, Deitch AD, deVere White RW.
    Cancer; 1998 Dec 15; 83(12):2534-9. PubMed ID: 9874460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.
    Dahiya R, Deng G, Chen KM, Chui RM, Haughney PC, Narayan P.
    Br J Cancer; 1996 Jul 15; 74(2):264-8. PubMed ID: 8688333
    [Abstract] [Full Text] [Related]

  • 10. Tumor suppressor gene p53 mutations in human prostate cancer.
    Kubota Y, Shuin T, Uemura H, Fujinami K, Miyamoto H, Torigoe S, Dobashi Y, Kitamura H, Iwasaki Y, Danenberg K.
    Prostate; 1995 Jul 15; 27(1):18-24. PubMed ID: 7603913
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.
    Calzolari A, Chiarelli I, Bianchi S, Messerini L, Gallo O, Porfirio B, Mattiuz PL.
    Am J Clin Pathol; 1997 Jan 15; 107(1):7-11. PubMed ID: 8980360
    [Abstract] [Full Text] [Related]

  • 12. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
    Dahiya R, Deng G, Selph C, Carroll P, Presti J.
    Biochem Mol Biol Int; 1998 Feb 15; 44(2):407-15. PubMed ID: 9530523
    [Abstract] [Full Text] [Related]

  • 13. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
    Soong R, Iacopetta BJ.
    Mod Pathol; 1997 Mar 15; 10(3):252-8. PubMed ID: 9071734
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X, Porter AT, Honn KV.
    Adv Exp Med Biol; 1997 Mar 15; 407():41-53. PubMed ID: 9321930
    [Abstract] [Full Text] [Related]

  • 16. p53 gene alterations in human prostate carcinoma.
    Effert PJ, McCoy RH, Walther PJ, Liu ET.
    J Urol; 1993 Jul 15; 150(1):257-61. PubMed ID: 8510267
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of non-tumor cell contamination on detection of p53 gene mutations in human gastric cancer cells by polymerase chain reaction single-strand conformation polymorphism analysis.
    Hong WS, Hong SI, Lee DS, Son Y.
    Korean J Intern Med; 1994 Jan 15; 9(1):20-4. PubMed ID: 8038143
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.